Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

pexacerfont

Tablets \& Capsules, Oral, 300mg loading dose then 100 mg, once daily, 1 week loading dose then 8 weeks

DRUG

escitalopram

Tablets \& Capsules, Oral, 10-20mg, once daily, 1 week loading dose then 8 weeks

DRUG

placebo

Tablets \& Capsules, Oral, 0 mg, once daily, 1 week loading dose then 8 weeks

Trial Locations (51)

10016

Bioscience Research, Llc, New York

10021

Fieve Clinical Services, Inc., New York

Social Psychiatry Research Institute, New York

10305

Behavioral Medical Research Of Staten Island, Staten Island

10312

Richmond Behavioral Associates, Staten Island

11516

Neurobehavioral Research, Inc., Cedarhurst

18103

Lehigh Valley Hospital, Allentown

20852

Capital Clinical Research Associates, Rockville

21208

Pharmasite Research, Inc., Baltimore

23112

Dominion Clinical Research, Midlothian

27609

Psychiatry And Clinical Research, Raleigh

28209

North Carolina Neuropsychiatry, Pa, Charlotte

28655

Medark Clinical Research, Morganton

29201

Carolina Clinical Research Services, Llc, Columbia

29406

Medical University Of South Carolina, Charleston

30080

Carman Research, Smyrna

32216

Clinical Neuroscience Solutions, Jacksonville

33407

Janus Center For Psychiatric Research, West Palm Beach

33613

Stedman Clinical Trials, Tampa

33702

Comprehensive Neuroscience, Inc., St. Petersburg

34613

Meridien Research, Brooksville

38119

Clinical Neuroscience Solutions, Inc., Memphis

45227

Community Research, Cincinnati

45408

Midwest Clinical Research Center, Dayton

46202

Indiana University School Of Medicine, Indianapolis

47905

Alpine Clinic, Lafayette

53562

Dean Foundation For Health Research & Education, Middleton

55101

Regions Hospital, Saint Paul

57105

Avera Research Institute, Sioux Falls

66206

Ctt, Inc., Prairie Village

67114

Cientifica, Inc. At Prairie View Inc., Newton

71104

J. Gary Booker, Md, Apmc, Shreveport

73103

Ips Research Company, Oklahoma City

73104

University Of Oklahoma Health Sciences Center, Oklahoma City

75231

Futuresearch Trials Of Dallas, Dallas

77008

Claghorn-Lesem Research Clinic, Houston

77057

Medlabs Research Of Houston, Inc., Houston

77090

Red Oak Psychiatry Associates, Pa, Houston

78756

Futuresearch Trials, Austin

80212

Radiant Research, Inc., Denver

85210

Pivotal Research Centers, Mesa

90024

Pacific Institute For Medical Research, Inc., Los Angeles

91505

Pacific Clinical Research Medical Group, Burbank

91786

Pacific Clinical Research Medical Group, Upland

92108

Affiliated Research Institute, San Diego

92627

Us Clinical Research Centers, Llc, Costa Mesa

97301

Oregon Center For Clinical Investigations, Inc. (Occi, Inc), Salem

06030

University Of Connecticut Health Center, Farmington

06360

Comprehensive Psychiatric Care, Pc, Norwich

02135

Boston Clinical Trials, Inc., Boston

02914

Rhode Island Mood & Memory Research Institute, East Providence

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY